| Writing Group Member | Employment | Research Grant | Other Research Support | Speakers' Bureau/ Honoraria | Expert Witness | Ownership Interest | Consultant/ Advisory Board | Other |
|---|---|---|---|---|---|---|---|---|
| Monica E. Kleinman Chair | Children's Hospital Boston | None | Children's Hospital of Philadelphia* | None | None | None | UpToDate* | PRG Science and Technology† |
| Jason E. Buick | University of Toronto | None | None | None | None | None | None | None |
| Nicole Huber | Cumberland Healthcare | None | None | None | None | None | None | None |
| Ahamed H. Idris | University of Texas Southwestern Medical Center at Dallas | None | None | None | None | None | Stryker, Belfast* | None |
| Michael Levy | Anchorage Fire Department | Celecor Therapeutics† | None | None | None | None | Stryker Emergency Care† | None |
| Sean G. Morgan | Denver Health Paramedics | None | None | None | None | None | None | None |
| Michelle MJ Nassal | The Ohio State University | NHLBI† | None | None | None | None | None | None |
| Matthew R. Neth | OHSU | ICECAP Co-Investigator* | None | None | None | None | None | None |
| Tatsuya Norii | University of New Mexico | Japanese Association for Acute Medicine* | None | None | None | None | None | None |
| Mark E. Nunnally | NYU University Langone Hospitals | None | None | None | None | None | None | None |
| Amber Rodriguez | American Heart Association National Center | None | None | None | None | None | None | None |
| Brian Walsh | Children's Hospital Colorado | Sentec*; Vyaire Medical* | None | None | None | FluidIQ† | Medtronic* | None |
| Ian R. Drennan Chair | University of Toronto; Ornge Critical Care and Transport Medicine; Sunnybrook Health Sciences | None | None | ZOLL Medical† | None | None | None | None |
This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $5,000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $5,000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.
*Modest.
†Significant.